Triglimisave LS 1 Tablet SR

Triglimisave LS 1 Tablet SR is a commonly prescribed medication used in the management of type 2 diabetes mellitus. It is a combination of three medications Glimepiride, Metformin, and Pioglitazone.

Each of these drugs contributes to diabetes control in different ways.

Glimepiride: This belongs to the sulfonylurea class and stimulates the release of insulin from the pancreas. It helps lower blood sugar levels by increasing the amount of insulin produced by the body.

Metformin: This is a biguanide that improves insulin sensitivity, reducing the amount of glucose produced by the liver and enhancing the body's response to insulin It also helps lower blood sugar levels.

Pioglitazone: A thiazolidinedione, it works by improving insulin sensitivity in the body's cells, allowing them to better respond to insulin. This results in lower blood sugar levels.

Follow the prescribed dosage provided by your healthcare provider This medication often comes in a fixed-dose combination, and the number of tablets to be taken may vary.

It is usually taken with meals to help reduce the risk of stomach upset.

Some common side effects of Triglimisave LS 1 Tablet SR are hypoglycemia, dizziness, sweating, and confusion. Gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort may occur. Additionally, some individuals might experience fluctuations in weight.

Due to the potential impact on the kidneys, those taking Metformin may undergo regular kidney function tests. Similarly, periodic liver function tests may be recommended because of potential effects on the liver.

If a dose is inadvertently missed, prompt action is necessary. Take the missed dose as soon as you remember, unless the next scheduled dose is imminent. In such cases, it's advisable to skip the missed dose to avoid doubling up.